#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pyoderma gangrenosum Idiopathic pulmonary fibrosis B-cell lymphoma Haemolytic uraemic syndrome Hereditary neuropathic amyloidosis Urethral valves Thalassaemia alpha Glycogen storage disease type I Bronchopulmonary aspergillosis Immune-mediated renal disorder Thermal burn Infertility male Splenic marginal zone lymphoma Autologous haematopoietic stem cell transplant Dilated cardiomyopathy More trials…

    Learn about Rare Diseases

    Waldenstrom’s macroglobulinaemia – Trials in Disease Ewing’s sarcoma metastatic – Basic Information Bronchiolitis obliterans syndrome – Trials in Disease Toxic epidermal necrolysis – Diagnostics Mucopolysaccharidosis III – Diagnostics Familial haemophagocytic lymphohistiocytosis – Treatment Alveolar rhabdomyosarcoma – Basic Information Brain stem glioma – Life with Disease Optic glioma Osteosarcoma metastatic – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Nortriptyline Hydrochloride Pimozide Folic Acid, Anhydrous A/(H3N2)-LIKE VIRUS ANTIGEN Propofol Ciltacabtagene Autoleucel Esketamine SAR444336 Prasugrel Nido-361 Azd5004 ETX-19477 Datopotamab Deruxtecan Riboflavin Sodium Phosphate LY4170156 Ocrelizumab Pelareorep Tetracycline Hydrochloride Upadacitinib Leniolisib Phosphate More therapies…

    Learn about Your Condition

    Hypoglycaemia Lymphangioma Tuberous sclerosis complex BRAF gene mutation Infective uveitis Neurofibrosarcoma Gastric cancer recurrent Osteosarcoma Hot flush Type 2 diabetes mellitus Myxoid liposarcoma Pyoderma gangrenosum Genital herpes Wheezing Breast cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study of PP1493 and PP1815 phage therapy for patients with knee or hip joint infections caused by Staphylococcus aureus after prosthetic surgery

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Staphylococcal infection
    • Medical device site joint infection
    Investigated Drugs:
    • Pp1493
    • Pp1815
    • Sodium Chloride
    France The Netherlands Spain

  • Study on Preventing Acute Kidney Injury After Heart Surgery Using Empagliflozin in Patients Undergoing Elective Cardiac Surgery

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiac function disturbance postoperative
    • Acute kidney injury
    Investigated Drugs:
    • Microcrystalline Cellulose
    • Empagliflozin
    Spain

  • A study evaluating a combination of glucagon and insulin lispro to improve insulin absorption in adults with Type 1 diabetes

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Type 1 diabetes mellitus
    Investigated Drugs:
    • Insulin Lispro
    • Glucagon
    Norway

  • Study on Organ Preservation in Advanced Rectal Cancer Patients Using Bleomycin and Electrochemotherapy After Initial Treatment

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Rectal cancer
    Investigated Drugs:
    • Bleomycin
    Italy

  • Study of Pembrolizumab with Standard Chemoradiation for Patients with Advanced Anal Cancer

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Anal cancer
    Investigated Drugs:
    • Pembrolizumab
    Norway

  • Study of L19TNF (onfekafusp alfa) with temozolomide chemoradiotherapy for newly diagnosed glioblastoma patients

    Not yet recruiting

    1 1 1 1
    Investigated Diseases:
    • Glioma
    Investigated Drugs:
    • Onfekafusp Alfa
    • Temozolomide
    Germany Italy
Previous Page
1 … 809 810 811 812 813 … 1,659
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!